Related Experiment Video

Updated: Mar 6, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.8K

STAT1 Inhibits MiR-181a Expression to Suppress Colorectal Cancer Cell Proliferation Through PTEN/Akt

Xingwen Zhang1,2, Xiang Li2, Fengbo Tan1

  • 1Department of Gastrointestinal Surgery, Xiangya Hospital, Central South University, Changsha, 410008, P.R. China.

Journal of Cellular Biochemistry
|March 22, 2017
PubMed

Insights

Signal transducers and activators of transcription 1 (STAT1) suppresses colorectal cancer (CRC) growth by down-regulating miR-181a, which accelerates proliferation via the PTEN/Akt pathway. This reveals a novel STAT1/miR-181a/PTEN pathway in CRC carcinogenesis.

Area of Science:

  • Molecular Biology
  • Oncology
  • Gene Regulation

Background:

  • Signal transducers and activators of transcription 1 (STAT1) has tumor-suppressor functions.
  • MicroRNAs (miRNAs) regulate gene expression and are implicated in tumorigenesis.
  • miR-181a is linked to poor prognosis in colorectal cancer (CRC).

Purpose of the Study:

  • To investigate the role of STAT1 in regulating miR-181a expression in colorectal cancer.
  • To elucidate the mechanism by which miR-181a influences CRC cell proliferation.
  • To identify the signaling pathway involved in STAT1/miR-181a-mediated CRC regulation.

Main Methods:

  • Utilized human colorectal cancer cell lines (LoVo and SW480).
  • Assessed STAT1's effect on cell growth and miR-181a expression.
  • Investigated STAT1 binding to the miR-181a promoter region.
  • Analyzed the impact of miR-181a on PTEN and the PTEN/Akt pathway.

Main Results:

  • STAT1 suppressed LoVo and SW480 cell growth by down-regulating miR-181a.
  • STAT1 directly regulates miR-181a expression via its promoter region.
  • miR-181a accelerates CRC cell proliferation by targeting PTEN, activating the PTEN/Akt pathway.
  • PTEN protein levels and p-AKT were modulated by STAT1 and miR-181a levels.

Conclusions:

  • STAT1 acts as a tumor suppressor in CRC by inhibiting miR-181a.
  • The STAT1/miR-181a/PTEN/Akt pathway is crucial in colorectal cancer development.
  • These findings provide new insights into CRC carcinogenesis and potential therapeutic targets.
Keywords:
AKTCOLORECTAL CANCERPTENSTAT1miR-181a

More Related Videos

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

14.5K
Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

2.3K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.0K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.5K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.5K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.5K